Showing results (251-260 of 379) with videos related to

Sort By:
Pageof 38
Journal of Thrombosis and Haemostasis : JTH|February 15, 2021
Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase responseLiam Townsend, Helen Fogarty, Adam Dyer, et al.
Journal of Thrombosis and Thrombolysis|July 10, 2014
D-Dimer elevation and adverse outcomesRim Halaby, Christopher J Popma, Ander Cohen, et al.
ERJ Open Research|July 7, 2018
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumoniaAntoni Torres, Michael S Niederman, Jean Chastre, et al.
Critical Care (London, England)|August 12, 2021
Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trialJean-François Timsit, Jennifer A Huntington, Richard G Wunderink, et al.
Frontiers in Immunology|May 24, 2021
Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-HealthLiam Townsend, Adam H Dyer, Aifric Naughton, et al.
BMJ Open Respiratory Research|September 25, 2025
Characterisation of nasopharyngeal colonisation by Staphylococcus aureus and the factors associated with colonisation in comorbid adults in a low- and middle-income countryJuan Olivella-Gómez, Natalia Sanabria-Herrera, Paula O Narvaez-Ramirez, et al.
Critical Care Medicine|June 30, 2018
Surviving Sepsis Campaign: Research Priorities for Sepsis and Septic ShockCraig M Coopersmith, Daniel De Backer, Clifford S Deutschman, et al.
Intensive Care Medicine|July 5, 2018
Surviving sepsis campaign: research priorities for sepsis and septic shockCraig M Coopersmith, Daniel De Backer, Clifford S Deutschman, et al.
Intensive Care Medicine|April 22, 2025
Outcomes in immunocompromised patients with acute hypoxemic respiratory failure treated by high-flow nasal oxygenElie Azoulay, Mélanie Métais, Virginie Lemiale, et al.
Pageof 38